Erythropoietin receptor expression in biopsy specimens from patients with uterine cervix squamous cell carcinoma

被引:9
作者
Shenouda, G
Mehio, A
Souhami, L
Duclos, M
Portelance, L
Belenkov, A
Chow, T
机构
[1] McGill Univ, Montreal Gen Hosp, Dept Radiat Oncol, Montreal, PQ H3G 1A4, Canada
[2] McGill Univ, Montreal Gen Hosp, Dept Pathol, Montreal, PQ H3G 1A4, Canada
关键词
erythropoietin; erythropoietin receptors; uterine cervix neoplasms;
D O I
10.1111/j.1525-1438.2006.00357.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia, an important mechanism of radioresistance, is a strong stimulus for erythropoietin (EPO) production. The stimulatory effects of EPO are mediated through the activation of its receptors, EPO receptors (EPORs). The objective of this study is to determine whether EPORs are expressed in biopsy specimens of patients with squamous cell carcinoma of the cervix. Eighteen biopsy specimens were studied after obtaining Institutional Review Board-approved consent. Standard immunohistochemistry techniques were utilized. Expression of EPORs was present in 16 out of 18 (88.9%) specimens. The intensity (qualitative) and the frequency (semiquantitative) of EPORs expression showed a statistically significant correlation (P= 0.00379). Statistical analysis was performed to determine whether EPORs expression is related to other parameters such as age, FIGO stage, histologic grade, and hemoglobin levels. Only age showed a statistically significant correlation with EPORs frequency of expression (P= 0.00878). Currently, work is in progress in our laboratory to study the radiobiologic effects of EPO on the radiation response of cultured cancer cell lines in vitro.
引用
收藏
页码:752 / 756
页数:5
相关论文
共 39 条
  • [31] The expression of PDGF-BB predicts curative effect in locally advanced esophageal squamous cell carcinoma treated by radiotherapy
    Er, Puchun
    Qian, Dong
    Zhang, Wencheng
    Zhang, Baozhong
    Wei, Hui
    Zhang, Tian
    Chen, Xi
    Wang, Yuwen
    Zhao, Jingjing
    Wang, Qi
    Pang, Qingsong
    Wang, Ping
    AGING-US, 2020, 12 (08): : 6586 - 6599
  • [32] Erythropoietin attenuates propofol-induced hippocampal neuronal cell injury in developing rats by inhibiting toll-like receptor 4 expression
    Zhang, Chun-yan
    Du, Juan
    Zhang, Rui
    Jin, Jin
    Qiao, Le-yan
    NEUROSCIENCE LETTERS, 2020, 716
  • [33] Paraneoplastic hormones: parathyroid hormone-related protein (PTHrP) and erythropoietin (EPO) are related to vascular endothelial growth factor (VEGF) expression in clear cell renal cell carcinoma
    Feng, Chen-chen
    Ding, Guan-xiong
    Song, Ning-hong
    Li, Xuan
    Wu, Zhong
    Jiang, Hao-wen
    Ding, Qiang
    TUMOR BIOLOGY, 2013, 34 (06) : 3471 - 3476
  • [34] A peculiar pattern of expression of the transferrin receptor (CD71) by reticulocytes in patients given recombinant human erythropoietin (rHuEPO): a novel marker for abuse in sport?
    Borrione, P.
    Parisi, A.
    Salvo, R. A.
    Spaccamiglio, A.
    Pautasso, M.
    Baraban, D.
    Piccoli, G. B.
    Pigozzi, F.
    Angeli, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2007, 21 (3-4) : 79 - 88
  • [35] N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin
    Machado, Eda
    Kandzia, Sebastian
    Carilho, Rita
    Altevogt, Peter
    Conradt, Harald S.
    Costa, Julia
    GLYCOBIOLOGY, 2011, 21 (03) : 376 - 386
  • [36] Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin plus G-CSF in cancer patients
    Joshi, SS
    Miller, K
    Jackson, JD
    Warkentin, P
    Kessinger, A
    CYTOTHERAPY, 2000, 2 (01) : 15 - 24
  • [37] Recovery from anti-recombinant-human-erythropoietin associated pure red cell aplasia in end-stage renal disease patients after renal transplantation
    Praditpornsilpa, K
    Buranasot, S
    Bhokaisuwan, N
    Avihingsanon, Y
    Pisitkul, T
    Kansanabuch, T
    Eiam-Ong, S
    Chusil, S
    Intarakumtornchai, T
    Tungsanga, K
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (03) : 626 - 630
  • [38] Prognosis of patients with locally advanced squamous cell carcinoma of the head and neckImpact of tumor cell expression of EPO and EPO-RPrognose für Patienten mit lokal fortgeschrittenem Plattenepithelkarzinom der Kopf-Hals-RegionEinfluss der Tumorzellexpression von EPO und EPO-R
    N.D. Seibold
    S.E. Schild
    M.P. Gebhard
    F. Noack
    D. Rades
    Strahlentherapie und Onkologie, 2013, 189 (7) : 559 - 565
  • [39] A Prospective Randomized Controlled Clinical Study to Investigate the Efficacy and Safety of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia Switched from Continuous Erythropoietin Receptor Activator Treatment
    Sezai, Akira
    Abe, Masanori
    Maruyama, Takashi
    Taoka, Makoto
    Sekino, Hisakuni
    Tanaka, Masashi
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)